Concord Drugs Limited share price
BSE: CONCORD
Key numbers
- Market cap
- ₹ 103 Cr
- Current price
- ₹ 78.33
- 52-week high / low
- ₹ 93 / 61
- Stock P/E
- 46.6
- Book value
- ₹ 43.2
- Dividend yield
- 0.00%
- ROCE
- 5.4%
- ROE
- 2.5%
- Debt to equity
- 0.30
- Sales growth (3 yrs)
- 14.8%
- Profit growth (3 yrs)
- 2.0%
- 1-year return
- 15.2%
About Concord Drugs Limited
Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products; ready-to-fill pellets and multiple unit pellets system; other drugs in the form of tablets, capsules, injectables such as small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. Concord Drugs Limited was incorporated in 1995 and is based in Hyderabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 14 | 10 | 17 | 38 | 21 |
| Operating profit | 1 | 1 | 1 | 1 | 2 |
| Net profit | 0 | 0 | 0 | 1 | 1 |
| EPS (₹) | 0.12 | 0.19 | 0.16 | 0.47 | 0.85 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.